A new ECDC report, issued today, provides policymakers in EU/EEA with a number of objectives and considerations on COVID-19 vaccination of 12-18-year-olds. The report highlights the current recommendations and status of COVID-19 vaccination of adolescents in EU/EEA countries, describes the epidemiology of COVID-19 in this age group and discusses vaccine effectiveness against transmission of SARS-CoV-2.

This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to adolescents (12- to 18-year-olds).

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 May 2021 and includes updates on COVID-19, dengue, influenza, Ebola virus disease and chikungunya.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 May 2021 and includes updates on COVID-19, influenza, measles, Salmonella Braenderup, Ebola virus disease and cholera.

This brief technical note was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.

Several SARS-CoV-2 variants have been identified. Some of these variants have mutations that (alone or in combination) may provide the virus with a selective advantage, such as increased transmissibility or the ability to evade the host immune response, or cause possible changes in pathogenicity, thus increasing disease severity.

A new dashboard provides an overview of the proportion of SARS-CoV-2 variants of concern and variants of interest among sequenced samples in EU/EEA countries, as well as sequencing volumes.

This technical report provides a summary of the evidence available at the time of the publication and what will be required in the future to support EU/EEA countries taking decisions on administration of the second dose, following a first dose of Vaxzevria. Since new evidence is being generated continuously and safety monitored on an ongoing basis, it is essential for readers to consider the latest available information.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 May 2021 and includes updates on COVID-19, dengue and influenza.

The aim of this Threat Assessment Brief is to assess potential public health implications of B.1.617 variants for EU/EEA countries, with a focus on lineage B.1.617.2.